Skip to main content
RNAC logo

RNAC · Cartesian Therapeutics, Inc.

$8.13 +0.00 (+0.00%) At close · Jul 22
Market Cap
$238.87M
Shares
29.38M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
Carsten Brunn $4,329,868
Metin Kurtoglu $2,474,034
Christopher Jewell $2,015,707
Blaine Davis $1,949,927
Milos Miljkovic $1,657,535
Fiscal 2024
Executive Total
Carsten Brunn $7,314,211
Blaine Davis $3,971,412
Metin Kurtoglu $2,713,064
Christopher Jewell $1,687,754
Milos Miljkovic $1,349,018
Fiscal 2023
Executive Total
Carsten Brunn $6,111,883
Peter G. Traber $3,780,920
Lloyd Johnston $2,697,590
Blaine Davis $2,494,759
Metin Kurtoglu $71,243
Chris Jewell $53,100
Christopher Jewell $53,100
Fiscal 2022
Executive Total
Carsten Brunn $4,292,242
Peter G. Traber $2,003,983
Kevin Tan $1,688,429
Takashi Kei Kishimoto $1,684,353
Lloyd Johnston $1,674,359
Blaine Davis $1,263,706
Metin Kurtoglu
Chris Jewell
Fiscal 2021
Executive Total
Carsten Brunn $3,671,395
Kevin Tan $2,601,622
Peter G. Traber $1,600,685
Takashi Kei Kishimoto $1,306,675
Lloyd Johnston $1,304,845
Bradford D. Dahms $868,053
Ann K. Donohue $361,493
Blaine Davis
Fiscal 2020
Executive Total
Carsten Brunn $2,095,347
Peter G. Traber $1,512,857
Bradford D. Dahms $959,356
Lloyd Johnston $889,306
Takashi Kei Kishimoto $807,333
Fiscal 2019
Executive Total
Carsten Brunn $1,986,495
Elona Kogan $1,359,486
Stephen Smolinski $964,635
Bradford D. Dahms $768,604
Fiscal 2018
Executive Total
Carsten Brunn $5,605,148
Stephen Smolinski $1,236,950
Key facts CIK 1453687 CUSIP 816212302 13F (30d) 9 filings 9 filers Visit website Investor relations